ENBREL Support™ Helps You
Help Your Patients

Whether your patients have private health insurance, are on Medicare, or are uninsured, we provide several options to help those with concerns about paying for ENBREL treatment.

With our reimbursement and prior authorization support, you will have assistance as you get your patients started on ENBREL. Or you can direct your patients to CheckENBRELInsurance.com, where they can enter their insurance information to find out specific coverage details for ENBREL.

Reimbursement Help

We can help take the confusion out of insurance verifications and prior authorizations (IV/PAs). This simple form gives health care professionals an efficient method to verify their patients' insurance authorization for treatment with ENBREL.

Download IV/PA Form

For help with prior authorizations for ENBREL, simply:

Fax Prior Authorization
forms to 1-877-474-3867

or

Call your dedicated
ENBREL Access Specialist
at 1-866-822-4680

Uninsured Patients

You may choose to refer uninsured patients to the ENcourage Foundation®—a nonprofit foundation supported by Amgen and Pfizer that has helped more than 30,000 eligible patients receive ENBREL. For more information, visit ENcourageFoundation.com.

Below is a sample letter of medical necessity that you can customize for your patients.

Download Medical Necessity Letter

You will need Adobe® Reader® to view certain documents on this page. If you do not already have it, download it for free from Adobe's website. Get Adobe® Reader®.

 
Important Safety Considerations

More than 170,000 people have used the ENBREL Support™ card to help pay for ENBREL

Learn about our program

Patient support every day

Help your patients start and stay on ENBREL with online videos and demos, services to keep patients on track, and live nurse support.

View our ongoing support
 
 
Close
You are leaving Enbrel.com/RheumPro
Please know that Amgen and Pfizer do not endorse and are not responsible for the content included on the site you are about to enter. Click the "Continue" button to proceed.

To return to ENBREL.com, click "Cancel" or close this window.

Privacy Policy  Terms of Use
This site is intended for US Audiences only.
©2013 Amgen, Inc., Thousand Oaks, CA 91320 and Pfizer Inc
Close
E-mail this page to a colleague
Please correct the fields marked in red
Send
This content is for US health care professionals only. Amgen and Pfizer will not use your e-mail address or your colleague's e-mail address for any other purpose. To learn more about our use of your information and your rights, please consult our Privacy Policy.
Close

Send another e-mail
Return to enbrel.com/RheumPro

Close
Notice

The following information is intended for use only by residents of the United States. Countries outside of the United States may have regulatory requirements or medical practices that are different than those in the United States and may require reference to different or additional information. Therefore, this information may not be appropriate outside of the United States.

If you are a resident of the United States or one of its territories, or a health care professional practicing your profession in the United States or one of its territories, please click below.

If you are a resident of a country other than the United States, please visit the Pfizer website and the Amgen website to find information about our offices around the globe.
Close
Phil Mickelson: A patient's perspective
Close
Disease activity vs. structural progression in RA